Fractyl Health, Inc. (GUTS)

Fractyl Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-99.77	-68.69	-77.09	-46.45
Depreciation & Amortization	0.99	0.68	0.29	0.45
Stock-Based Compensation	8.61	14.43	6.79	3.14
Other Adjustments	0.37	-21.52	26.2	-2.14
Change in Receivables	-	0.02	-0.02	-
Changes in Inventories	-	-	-0.07	-
Changes in Accounts Payable	1.82	2.69	-0.43	0.01
Changes in Accrued Expenses	5.99	5.65	0.54	-0.93
Changes in Other Operating Activities	0.55	1.23	0.97	-0.32
Operating Cash Flow	-81.35	-65.52	-42.82	-46.24
Capital Expenditures	-0.99	-1.77	-0.36	-0.06
Investing Cash Flow	-0.99	-1.77	-0.36	-0.06
Long-Term Debt Issued	-	-	28.43	20.08
Long-Term Debt Repaid	-0.39	-0.19	-0.08	-16.05
Net Long-Term Debt Issued (Repaid)	-0.39	-0.19	28.35	4.03
Issuance of Common Stock	-	104.27	0.05	0.32
Net Common Stock Issued (Repurchased)	-	104.27	0.05	0.32
Other Financing Activities	-	-2.85	-0.96	-
Financing Cash Flow	1.88	101.23	27.44	4.35
Net Cash Flow	-80.46	33.94	-15.75	-41.95
Beginning Cash & Cash Equivalents	107.01	37.78	53.52	95.47
Ending Cash & Cash Equivalents	26.55	71.72	37.78	53.52
Free Cash Flow	-82.34	-67.29	-43.18	-46.3
FCF Margin	-484370.59%	-72350.54%	-35985.00%	-
Free Cash Flow Per Share	-1.69	-1.55	-20.75	-23.26
Levered Free Cash Flow	-91.79	-62.14	-64.99	-60.45
Unlevered Free Cash Flow	-91.48	-85.05	-49.9	-50.23

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q